Espa3.Sa

Espa3's capital structure is characterized by a debt-to-equity ratio of 0.88, indicating a moderate reliance on debt financing. The company holds cash and equivalents of BRL 128.16 million, but with long-term debt of BRL 753.04 million, its net cash position is negative. The liquidity risk is assessed as medium, with a current ratio of 1.69, suggesting the company has sufficient short-term assets to cover its short-term liabilities.

Profitability metrics for Espa3 are below typical industry benchmarks. The company's return on equity (ROE) is 1.83%, and return on assets (ROA) is 0.71%, both of which are relatively low. These figures suggest that Espa3 is not generating strong returns relative to its equity and asset base, which could be a concern for investors seeking higher returns.

Espa3 operates as a single-segment entity, with all revenue derived from personal services. There is no geographic diversification data available, but the company's revenue concentration in a single business line increases its exposure to market-specific risks. The lack of segment or geographic diversification could limit its ability to adapt to changing market conditions.

The company's growth trajectory appears to be modest. Espa3 reported revenue of BRL 1.09 billion in the latest period, with an operating income of BRL 171.67 million. While the company has a positive operating cash flow of BRL 115.90 million, its free cash flow is only BRL 60.06 million. The capital expenditure of BRL 53.06 million indicates ongoing investment, but the scale of investment is relatively small compared to the company's total assets.

Risk factors for Espa3 include its medium liquidity risk and the potential for dilution, although the latter is currently assessed as low. The company's net cash position is negative after subtracting total debt, which could limit its ability to fund operations or pursue growth opportunities without external financing. No significant dilution sources have been identified in the latest filings.

Recent events and disclosures for Espa3 include analyst estimates that are uniformly set at a price target of BRL 1.28, with a mean recommendation of 3.00 (Hold). There are no strong buy or buy recommendations, indicating a cautious outlook from analysts. No recent filings or transcripts have been identified that would suggest significant changes in the company's strategic direction or financial health.